David Aguillón

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia

Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease

Viscous dynamics associated with hypoexcitation and structural disintegration in neurodegeneration via generative whole‐brain modeling

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man

Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s disease

The BrainLat project, a multimodal neuroimaging dataset of neurodegeneration from underrepresented backgrounds

Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease

Genetic associations with age at dementia onset in the <i>PSEN1 E280A</i> Colombian kindred

Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia

Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease

Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non‐demented individuals with autosomal‐dominant Alzheimer's disease

Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report